RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
Subscribe or renew to PPM

All Pharmacological Articles

Opioid antagonists, such as naltrexone and naloxone, may help reduce side effects and address drug deficiencies in chronic pain treatment.
FDA approval of biosimilars in comparison to biologics for the treatment of chronic pain raises issues of efficacy.
UN calls untreated pain cruel and inhumane, yet in the US chronic pain patients are losing access to needed opioid therapy to manage severe, intractable pain conditions.
The best approaches to manage pain relief to most effectively address post-surgical pain.
Ask the Expert: A discussion of the pain relief potential from Na1.7 Inhibitors for neuropathic pain disorders.
Readers raise questions about the one-sided view of the so-called opioid-epidemic, hormone therapy, and long-term opioid care.
Expert give you advice on how to switch from Opanan ER to another long-acting opioid.
An argument in support of providing patients with an opioid prescription for dosages over 90 MME daily to manage severe chronic pain.
While there are people who misuse and abuse opioids, there are also many patients with severe, chronic, intractable pain for whom a safe and effective weaning approach is needed.
Assessment of abuse-deterrent opioid medications designed to lessen access to active ingredients while maintaining analgesic effects for chronic pain patients with appropriate need.
This month's Editor's Memo focuses on how Medicare and Medicaid are planning on adopting CDC Guidelines for Safe Opioid Prescribing.
A perspective on several common terms that are widely used by pain practitioners but often are misunderstood by professionals, patients, the general public, and the media.
A multitude of pharmacokinetic changes that occur with aging should be considered when pain prescribers consider which medications to prescribe to avoid drug-drug interactions in the elderly.
Pain practitioners are urged to recognize painful genetic disorders, which fall into 3 categories: connective tissue, metabolic, and neurologic, as they require aggressive, palliative pain care for these usually progressive conditions.
Recommendations concerning liver function tests for Duloxetine, prescribed for neuropathic pain.
SHOW MAIN MENU
SHOW SUB MENU